NORLIPASE Trademark of Nordmark Arzneimittel GmbH & Co. KG - Serial Number 79097498

NORLIPASE Trademark

Trademark Overview

On Wednesday, April 13, 2011, a trademark application was filed for NORLIPASE with the United States Patent and Trademark Office. The USPTO has given the NORLIPASE trademark a serial number of 79097498. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, April 14, 2021. This trademark is owned by Nordmark Arzneimittel GmbH & Co. KG. The NORLIPASE trademark is filed in the Pharmaceutical Products category with the following description:

Chemical products for medical purposes, pharmaceutical and veterinary products, namely, enzymes for medical purposes, enzyme preparations for medical purposes, and medicines in the nature of pancreatic enzyme replacement therapy

General Information

Serial Number	79097498
Word Mark	NORLIPASE
Filing Date	Wednesday, April 13, 2011
Status	404 - IR CANCELLED - US REGISTRATION CANCELLED
Status Date	Wednesday, April 14, 2021
Registration Number	4092887
Registration Date	Tuesday, January 31, 2012
Mark Drawing	4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	Tuesday, November 15, 2011

Trademark Statements

Goods and Services

Chemical products for medical purposes, pharmaceutical and veterinary products, namely, enzymes for medical purposes, enzyme preparations for medical purposes, and medicines in the nature of pancreatic enzyme replacement therapy

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	006, 018, 044, 046, 051, 052
Class Status Code	F - NOT AVAILABLE
Class Status Date	Friday, September 7, 2018
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	Nordmark Arzneimittel GmbH & Co. KG
Party Type	30 - Original Registrant
Legal Entity Type	99 - Other
Address	DE

Party Name	Nordmark Arzneimittel GmbH & Co. KG
Party Type	20 - Owner at Publication
Legal Entity Type	99 - Other
Address	DE

Party Name	Nordmark Arzneimittel GmbH & Co. KG
Party Type	10 - Original Applicant
Legal Entity Type	99 - Other
Address	DE

Trademark Events

Event Date	Event Description
Wednesday, November 3, 2021	NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Wednesday, November 3, 2021	DEATH OF INTERNATIONAL REGISTRATION
Friday, July 26, 2019	TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, June 1, 2019	TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, June 1, 2019	INVALIDATION PROCESSED
Tuesday, May 7, 2019	TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 7, 2018	CANCELLED SECTION 71
Saturday, May 19, 2012	FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 1, 2012	FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 1, 2012	FINAL DISPOSITION PROCESSED
Monday, April 30, 2012	FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 31, 2012	REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2011	PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2011	NOTICE OF PUBLICATION
Friday, October 7, 2011	LAW OFFICE PUBLICATION REVIEW COMPLETED
Sunday, October 2, 2011	APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 30, 2011	AMENDMENT FROM APPLICANT ENTERED
Friday, September 30, 2011	CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 21, 2011	ASSIGNED TO LIE
Monday, September 19, 2011	FAX RECEIVED
Sunday, August 7, 2011	REFUSAL PROCESSED BY IB
Thursday, July 21, 2011	NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 21, 2011	REFUSAL PROCESSED BY MPU
Wednesday, July 20, 2011	NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, July 19, 2011	NON-FINAL ACTION WRITTEN
Tuesday, July 19, 2011	ASSIGNED TO EXAMINER
Tuesday, June 14, 2011	APPLICATION FILING RECEIPT MAILED
Friday, June 10, 2011	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, June 9, 2011	SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

norlipase purposes medical enzyme products nature pancreatic therapy medicines replacement enzymes